GLP-1 Medications Influence Food Purchases and Dietary Choices
GLP-1 medications, such as Ozempic and Wegovy, have gained popularity over the past five years due to their effectiveness in supporting weight loss. These medications work by mimicking a natural gut hormone known as GLP-1, which plays a role in regulating appetite and blood sugar levels. In addition to reducing hunger, GLP-1s help diminish the cravings that often lead to unhealthy eating habits, allowing individuals to make more mindful food choices.
A study published in JAMA Network Open aimed to assess how GLP-1 medications influence the types of foods people purchase, rather than just the quantity they consume. Researchers examined purchasing data from 1,177 adults in Denmark, including 293 individuals who had recently started a GLP-1 medication and 88 who had not. The study tracked nearly 2 million food purchases from 2019 to 2022, providing a comprehensive look at dietary changes associated with these medications.
The findings indicated that participants who began using GLP-1 medications made notable changes to their grocery selections. On average, their purchases contained fewer calories, sugars, carbohydrates, and saturated fats while including slightly more protein. Additionally, there was a discernible shift from ultra-processed foods to more minimally processed options. In contrast, those who did not start a GLP-1 medication exhibited an increase in the purchase of foods that were higher in sugar, carbohydrates, and calories over the same period.
This side-by-side comparison lends weight to the conclusion that the dietary improvements observed in the GLP-1 group are likely linked to their medication use. However, researchers caution that the changes are modest at the individual level. For instance, the study reported a decrease of only 2.1 calories or 0.6 grams of sugar per 100 grams of food, which does not equate to drastic dietary overhauls but rather indicates a trend towards healthier, more consistent food choices, such as opting for whole-grain bread instead of white bread.
Examining the Impact of GLP-1 Medications on Food Preferences
These results align with previous research that has shown how GLP-1 medications can affect food preferences. A randomized controlled trial conducted in 2017 found that weekly administration of semaglutide led to a significant reduction in total daily energy intake, decreased hunger, and a lowered preference for high-fat foods. More recent findings from 2025 further support these observations, indicating that oral semaglutide is associated with reduced cravings for sweets and starchy foods, with carbohydrates showing the most significant decrease.
Navigating Nutritional Choices with GLP-1 Medications
While the research highlights the potential of GLP-1 medications to shift food purchasing behavior positively, it also underscores the importance of mindful eating habits. As appetite is suppressed, individuals may inadvertently neglect essential nutrients such as protein and fiber. Collaborating with a healthcare practitioner can help ensure that meal planning remains balanced and nutritious, supporting overall health and weight management goals.
In conclusion, GLP-1 medications are indeed influencing how people buy and consume food, steering them towards healthier options. However, the appetite-suppressing effects of these medications mean that every food choice carries more significance, emphasizing the need for a focus on nutrient-rich foods and adequate micronutrient intake to maintain a balanced diet.




